Navigation Links
Sutter Solano Cancer Center Offers Oncology Patients Customized Cancer Treatment
Date:11/8/2007

Breakthrough IMRT technology targets tumors, spares healthy tissue

VALLEJO, Calif., Nov. 8 /PRNewswire/ -- Sutter Solano Cancer Center's oncology patients now have access to the most advanced and accurate radiation therapy system available. Intensity Modulated Radiation Therapy (IMRT) offers patients in the North Bay region customized cancer treatment resulting in quicker, more accurate treatment for several types of cancers, including breast, prostate, head, neck and lung cancers.

"The amazing thing about this new technology is that it promises to help increase survival rates and decrease complications," says Janice Hoss, R.N., director of cancer services at Sutter Solano Cancer Center. "IMRT is more precise -- sparing healthy tissue and allowing for treatments that can be custom designed for each patient's situation."

Using advanced 3D computer modeling, SmartBeam(TM) IMRT carefully targets tumor cells by wrapping beams of radiation around healthy tissue and vital organs. This precise targeting allows higher, more effective doses of radiation to be delivered to cancerous cells, giving clinicians a better possibility of fully eradicating the tumor, rather than simply causing a temporary regression.

"We can form the shape of the radiation beam to the exact shape of the tumor from any angle," says Hoss. "The result is shorter treatment times and fewer complications. This truly represents a major breakthrough in cancer treatment that benefits our patients' quality of life and the community we serve."

Recent studies performed at Memorial Sloan-Kettering Cancer Center in New York, N.Y., for example, have shown that IMRT leads to improved cure rates and decreased complications. The studies demonstrated that in certain cases of cancer, cure rates were improved from 43 to 96 percent using IMRT, and the complication rate dropped from six percent to two percent.

SSCC continues to provide area residents with the same breakthrough cancer-treating technology used in medical facilities with world-class reputations. Most recently, SSCC has added respiratory gating capabilities. Primarily used for certain cases of breast and lung cancer, respiratory gaiting allows clinicians to place radiation beams precisely and track the position of tumors as they move when a patient breathes. SSCC expects to start treating its first patients using respiratory gating within the next month.

About Sutter Solano Medical Center

For more than 100 years, SSMC has been committed to the community by providing emergency care, delivering babies, and serving others in time of need. The medical center has 111 licensed beds and is fully accredited by The Joint Commission, an independent, non-profit with the mission to continuously improve the safety and quality of care provided to the public.

Sutter Solano Cancer Center is fully accredited by the Commission on Cancer of the American College of Surgeons -- a recognition only one in four cancer centers receive. Comprehensive cancer services include chemotherapy, infusion therapy, laboratory and pathology, pain management and radiation therapy.

SSMC is part of Sutter Health, a not-for-profit network of hospitals, doctors, and nurses who share expertise and resources to advance health care quality.


'/>"/>
SOURCE Sutter Solano Medical Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Nurses Send Sutter a Clear Message
2. Sutter Health Medical Groups Among the Best for Health Care Quality
3. Solano Regional Medical Group and Sutter Regional Medical Foundation Recognized by Integrated Healthcare Association (IHA)
4. Sutter Moves to Reduce Public Accountability, Slash Hospital Beds
5. Sutter Violating State Safety Laws on Assuring Proper Competency Validation of Strike Staff, Say RNs
6. Sutter Solano Cancer Center Offers Advice, Free Lecture During Breast Cancer Awareness Month
7. CNA Presents New Data on Sutters Medical Redlining
8. Sutter Fairfield Surgical Center Ranks Best in Region
9. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
10. Survival differences by race most apparent in advanced stages of breast cancer
11. MRI finds breast cancer before it becomes dangerous
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: